Clarus Securities Inc.

Latest News

Market Upheaval in Q4 Still Provided Specialized Access

Clarus capital markets activities continued in Q4 2018 even though markets were very volatile and unforgiving.  Clarus remained active with transactions for gold mining exploration companies and cannabis related companies.  In the cannabis space, considerable M&A activity has emerged on the Canadian front as the market sorts out those that can deliver quality product consistently...
Learn More
Brock Winterton |

Emergence of World Leading Financial Market in the Cannabis Space

Markets have taken a more volatile turn resulting in more cautious and less committed trading activity. Clarus has been able to remain active in important investment themes with some highly targeted financings in the cannabis, blockchain, technology, specialty healthcare segments. M&A has emerged in the Gold sector as larger players...
Learn More
Brock Winterton |

What's Happening at Clarus...

While uncertainty continues to roil most segments of the market due to trade concerns, the passage of cannabis legislation in Canada removed the final legal uncertainty for this dynamic new industry. Capital market activity in the cannabis space was widespread in June and Clarus was once again one of the leaders raising or advising on $294 million in...
Learn More
Brock Winterton |

Greater Volatility but Investment Themes Resonate

Markets have taken a more volatile turn resulting in more cautious and less committed trading activity. Clarus has been able to remain active in important investment themes with some highly targeted financings in the cannabis, blockchain, technology, specialty healthcare segments. M&A has emerged in the Gold sector as larger players...
Learn More
Brock Winterton |

Remaining At the Centre of Key New Industries

The evolving market focus on cannabis related companies translated into several lead, co-lead and manager roles including two lead roles for Aphria Inc. raising over $200 million supporting its aggressive growth plans and a co-lead role for MedReleaf in its $100 transaction to also support a build-out of capacity. We also helped Liberty Health Services with...
Learn More
Brock Winterton |

Execution Remains Strong in Q2/17

During a quarter where agency trading just got more challenging, markets also saw several financings fail to fully sell. Fortunately, Clarus continued its successful capital raising activities including executing some sizable IPO’s.  In total, we raised $503 million in eight transactions of which we were lead or co-lead in six.  Noteworthy, four transactions were of $80 million or more....
Learn More
Brock Winterton |

Adding Value

Clarus is an idea shop. We don’t cover all sectors and we don’t cover all the names in a space. By being very select in a sector, we try to deliver the best ideas that generate the best absolute returns to investors. We have been helping our clients with ideas like these lately...
Learn More
Brock Winterton |

Markets Were Open in Q1 2017

As markets opened up in Q1 2017, Clarus nimbly participated with a very active calendar. We participated in 15 transactions raising a total of $273 million. The cannabis space remained active with four transactions, the mining exploration space heated up with five deals and the healthcare, technology and special sits area saw six transactions....
Learn More
Brock Winterton |

Field of Greens

Clarus was active in Q4/16 as it was involved in seven transactions raising a total of $444 million. We maintained our marquee position in the emerging marijuana space having participated in four transactions (two as lead) raising a total of $105 million....
Learn More
Brock Winterton |

New Ideas at Clarus

At Clarus, we’re dedicated to staying at the forefront of emerging trends. Take a look at some of the new ideas we’ve been involved within the past few months...
Learn More
Brock Winterton |
Click For More